Asep Medical Holdings Inc (ASEP.CN)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in CADTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CAD m | 0 | 0 | 0 | 0 | - | - | - | - |
| Operating profit | CAD m | -8 | - | ||||||
| Net profit | CAD m | -0 | -2 | -6 | -8 | - | - | - | - |
| EPS reported | CAD | -0.13 | - | ||||||
| Operating cashflow per share | CAD | -0.04 | - | ||||||
| Capex per share | CAD | 0.00 | - | ||||||
| FCF per share | CAD | -0.04 | - | ||||||
| Free cash flow | CAD m | -3 | - | ||||||
| Net debt | CAD m | -0 | - | ||||||
| Book value equity | CAD m | 13 | - | ||||||
| Book value per share | CAD | 0.20 | - | ||||||
| Number of shares | m | 62.24 | - | ||||||
| DPS (TTM paid) | CAD | 0.00 | - |
Financial summary
Financials in CADTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 10.12 | - | ||||||
| P/S LTM | x | 6,035.12 | - | ||||||
| P/FCF LTM | x | -46.96 | - | ||||||
| EV/EBITDA LTM | x | -15.68 | - | ||||||
| EV/Sales LTM | x | 6,033.01 | - | ||||||
| Earnings Yield LTM | % | -6.45% | - | ||||||
| FCF Yield | % | -2.13% | - | ||||||
| Quality | |||||||||
| ROE | % | -65.23% | - | ||||||
| ROIC | % | -31.34% | - | ||||||
| Operating margin | % | -365.24% | - | ||||||
| Gross margin | % | -5.38% | - | ||||||
| FCF/Sales | % | -12852.74% | - | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | - | - | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | - | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | - | ||||||
| FCF/Debt | x | -135.85 | - | ||||||
| Net Debt/EBITDA | x | 0.01 | - | ||||||
| EBIT/Net interest | x | -28,597.27 | - | ||||||
| Net debt/market cap | % | +0.02% | - | ||||||
| Net debt/Equity | x | -0.00 | - | ||||||
| Gross debt/equity | x | 0.00 | - | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Asep Medical Holdings Inc. is dedicated to advancing medical solutions, primarily through its subsidiary, ASEP Medical Inc. The company's core focus involves pioneering an early diagnostic method for Sepsis, as well as developing innovative peptide-based therapeutic treatments applicable to a variety of medical conditions. Established in 2020, this Vancouver, Canada-based firm was formerly known as Trenchant Life Sciences Investment Corp. before adopting its present identity.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Asep Medical Holdings Inc (ASEP.CN)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Asep Medical Holdings Inc. is dedicated to advancing medical solutions, primarily through its subsidiary, ASEP Medical Inc. The company's core focus involves pioneering an early diagnostic method for Sepsis, as well as developing innovative peptide-based therapeutic treatments applicable to a variety of medical conditions. Established in 2020, this Vancouver, Canada-based firm was formerly known as Trenchant Life Sciences Investment Corp. before adopting its present identity.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free